InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: Ando Financing Firm post# 1065

Monday, 03/31/2014 8:46:25 PM

Monday, March 31, 2014 8:46:25 PM

Post# of 2098
I'm not worried about who paid what or who didn't pay what to attend FDA meetings regarding Zohydro. Political pressure isn't going to stop to remove highly addictive opioids that don't carry abuse deterrent properties whether or not the ADT in those ADT opioids are highly effective or not for that matter.

Take Purdue's ADT version of Oxycontin that the FDA gave approval to and its only ADT seal of approval to date. It's clear you give me some Coca Cola and some lemon juice and in the morning it's pure non ADT oxycontin with the highly addictive properties undeterred.

Zohydro is no different accept I don't need the coca cola and lemon juice to begin with. What I'm pleased to see on Zogenix's website is that the company is working on an ADT version of Zohydro. The company should've put out an ADT version of Zohydro first and then the non ADT version second. That way it wouldn't be in this mess to begin with.


Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.